Groundbreaking research presented today at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) that could significantly reduce or even eliminate the need for insulin therapy.
FDA+ roundup: FDA continues to loosen standard of evidence for novel drug approvals — JAMA research letter
The FDA is continuing to lower the bar of its approval standards for novel drug applications, according to a new analysis of evidence on approvals